Table 1 Primary and Secondary Outcome Measures
From: Relaxation and exercise in lymphoma survivors (REIL study): a randomised clinical trial protocol
Outcome measured | Instrument | Guidelines | When assessed | ||
|---|---|---|---|---|---|
Baseline | Midway 6 weeks | End of intervention 12 weeks | |||
Primary outcome | |||||
āQuality of Life | EORTC QLQ-C30 | Self-reported Questionnaire | ā | ā | ā |
Secondary outcomes | |||||
āBody Composition | Height, Weight, Bioimpedance analysis ā BMI, Body Fat % - TANITA BC-418 Body Composition Analyzer | Same investigator and equipment, time of day and clothing kept similar where possible | ā | ā | ā |
āCardiovascular status ā Resting BP, HR, SpO2 | Omron M10-IT electronic BP monitor, Solaris Finger Pulse Oximeter S10A | ā | ā | ā | |
āPulmonary Function ā FEV1, FVC, FER, PEF | Hand-held Micro 1 Medical Microspirometer | British Thoracic Society, 2013 | ā | ā | ā |
āMuscle Strength ā Grip Strength | JamarĀ® Hydraulic Hand Dynamometer | American College of Sports Medicine, 2014 | ā | ā | ā |
āFunctional Exercise Capacity | Six Minute Walk Test | American Thoracic Society, 2002 | ā | ā | ā |
āPhysical Well-being, Social/Family Well-being, Emotional Well-being, Functional Well-being | FACT-Lym | Self-reported Questionnaire | ā | ā | ā |
āAnxiety and Depression | HADS | ā | ā | ā | |
āFeelings and Perceptions about participating in programme | End of Study Questionnaire | Open-ended Questionnaire mailed to participantsā home | Ā | Ā | ā |